DocumentOngoingNews

Over 55 000 people initiated on groundbreaking Lenacapavir

GCIS / SAnewsRef: GOVNEWS-84142 at https://www.sanews.gov.za

Official source

Source domain: sanews.gov.za

Collected on 9 September 2026

Always confirm details on the official source before acting.

What this means

This document is a government health progress update from SAnews reporting that over 55,123 people in South Africa have been initiated on Lenacapavir, a twice-yearly injectable HIV prevention medication, as of 7 September 2026. The rollout, launched in June 2026, is ongoing across 360 public health facilities in six provinces, with strong uptake among pregnant and breastfeeding women. The Department of Health confirms the medication is safe and effective, supported by regulatory approval and continuous monitoring.

What this document offers

Read out of this document by Govermate's AI, in its own words. Each one quotes the line it came from — confirm on the official source before acting.

medical prevention treatmentOngoing

Lenacapavir HIV prevention injection

A twice-yearly injectable medication approved for preventing HIV infection, available at public health facilities across six provinces. It is part of a comprehensive PrEP-choice programme and is especially recommended for pregnant and breastfeeding women due to high uptake among this group.

Who it is for: people in South Africa seeking HIV prevention, especially pregnant and breastfeeding mothers
How to act on it: Visit any of the 360 public health facilities across 24 districts in six provinces where Lenacapavir is being rolled out; consult a healthcare worker to determine eligibility and receive the injection.

The document's recorded date is 7 September 2026. Confirm on the official source.

Facts

Places

Gauteng, KwaZulu-Natal, North West, Western Cape, Mpumalanga

Reference

GOVNEWS-84142 at https://www.sanews.gov.za

Key Takeaways

55 123
7 September 2026
June 2026
Gauteng
KwaZulu-Natal
North West
Western Cape
Mpumalanga
Eastern Cape
360 public health facilities
24 districts
six provinces
Lenacapavir
HIV prevention
PrEP-choice programme
South African Health Products Regulatory Authority
Department of Health (DoH)
President Cyril Ramaphosa
Dr Aaron Motsoaledi
South African Health Products Regulatory Authority
GCIS / SAnews
Roze Britz
Janine Arcangeli
Zanele Mngadi
Gauteng
KwaZulu-Natal
North West
Western Cape
Mpumalanga
Eastern Cape

Dates

Opening Date

8 September 2026